Expert Consultations: Real-World Answers

TMS in Psychiatry: A Practical Update – Interview

Published on November 1, 2019 Expired on April 1, 2023

Guest

Dana Wang

To unlock this audio you need to become a Silver, Gold, Silver extended or Gold extended Member.

Check Our CME Program

Downloads for Offline Access

Download Audio File (MP3)

Interview Highlights

Patients with depression who benefit most from TMS are the ones who are less medication resistant with shorter duration of the disorder.
Relapse rates in patients with depression who underwent TMS are similar to those of ECT; however, TMS does not have the cognitive side effects of ECT.
TMS for OCD gained FDA’s approval in August 2018.

Text Version

This edition of Psychopharmacology Institute’s Expert Interviews features Simon Kung, M.D.

Dr. Kung is an associate professor of psychiatry at Mayo Clinic in Rochester, Minnesota, and is an expert in transcranial magnetic stimulation (TMS). In this lecture, he will be discussing the background of TMS and how to use it in clinical treatment.
Dana Wang, M.D.: Could you start by telling us

Unlock this Expert Consultation and earn 0.50 CMEs
Become a Silver, Gold, Silver extended or Gold extended Member.

Get Instant Access

Already have an account? Sign in

Learning Objectives:

After completing this activity, the learner will be able to:

Determine which psychiatric conditions benefit from TMS so as to select the most appropriate patients for this treatment.
Outline the standard course of treatment with TMS to accurately discuss this treatment in clinical settings.

Original Release Date: November 1, 2019

Review and Re-release Date: March 1, 2023

Expiration Date: April 1, 2023

Relevant Financial Disclosures:

The following planners, faculty, and reviewers have the following relevant financial relationships with commercial interests to disclose:

Dr. Kung has disclosed the following relationships:

Psychopharmacology Institute: preparing CME presentation

All of the relevant financial relationships listed for these individuals have been mitigated.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

View the required educational content provided on this course page.
Answer the quiz for promoting retention of knowledge.
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Simon Kung, M.D.